BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32798157)

  • 1. Retrospective Planning Study of Patients with Superior Sulcus Tumours Comparing Pencil Beam Scanning Protons to Volumetric-Modulated Arc Therapy.
    Wong SL; Alshaikhi J; Grimes H; Amos RA; Poynter A; Rompokos V; Gulliford S; Royle G; Liao Z; Sharma RA; Mendes R
    Clin Oncol (R Coll Radiol); 2021 Mar; 33(3):e118-e131. PubMed ID: 32798157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.
    Abbas AS; Moseley D; Kassam Z; Kim SM; Cho C
    J Appl Clin Med Phys; 2013 May; 14(3):4269. PubMed ID: 23652258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.
    Liu C; Sio TT; Deng W; Shan J; Daniels TB; Rule WG; Lara PR; Korte SM; Shen J; Ding X; Schild SE; Bues M; Liu W
    J Appl Clin Med Phys; 2018 Nov; 19(6):140-148. PubMed ID: 30328674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Dosimetric Comparative Study of Carbon-Ion Radiotherapy Versus X-ray Volumetric Modulated Arc Therapy for Stage III Non-Small-Cell Lung Cancer.
    Li XJ; Li CR; Ye YC; Zhang YS; Zong XQ; Feng CL
    Niger J Clin Pract; 2024 Feb; 27(2):236-243. PubMed ID: 38409153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
    Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
    Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Planning analysis for locally advanced lung cancer: dosimetric and efficiency comparisons between intensity-modulated radiotherapy (IMRT), single-arc/partial-arc volumetric modulated arc therapy (SA/PA-VMAT).
    Jiang X; Li T; Liu Y; Zhou L; Xu Y; Zhou X; Gong Y
    Radiat Oncol; 2011 Oct; 6():140. PubMed ID: 22014217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.
    Warren S; Partridge M; Bolsi A; Lomax AJ; Hurt C; Crosby T; Hawkins MA
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):199-207. PubMed ID: 27084641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small spot size versus large spot size: Effect on plan quality for lung cancer in pencil beam scanning proton therapy.
    Rana S; Rosenfeld AB
    J Appl Clin Med Phys; 2022 Feb; 23(2):e13512. PubMed ID: 34989458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.
    Shan J; Yang Y; Schild SE; Daniels TB; Wong WW; Fatyga M; Bues M; Sio TT; Liu W
    Med Phys; 2020 Nov; 47(11):5428-5440. PubMed ID: 32964474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced pencil beam scanning Bragg peak FLASH-RT delivery technique can enhance lung cancer planning treatment outcomes compared to conventional multiple-energy proton PBS techniques.
    Wei S; Lin H; Isabelle Choi J; Shi C; Simone CB; Kang M
    Radiother Oncol; 2022 Oct; 175():238-247. PubMed ID: 35961583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapies.
    Liu C; Bhangoo RS; Sio TT; Yu NY; Shan J; Chiang JS; Ding JX; Rule WG; Korte S; Lara P; Ding X; Bues M; Hu Y; DeWees T; Ashman JB; Liu W
    J Appl Clin Med Phys; 2019 Jul; 20(7):15-27. PubMed ID: 31112371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-fraction motion robustness and organ sparing potential of proton therapy for cervical cancer.
    Gort EM; Beukema JC; Matysiak W; Sijtsema NM; Aluwini S; Langendijk JA; Both S; Brouwer CL
    Radiother Oncol; 2021 Jan; 154():194-200. PubMed ID: 32956707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target coverage and cardiopulmonary sparing with the updated ESTRO-ACROP contouring guidelines for postmastectomy radiation therapy after breast reconstruction: a treatment planning study using VMAT and proton PBS techniques.
    Milligan MG; Zieminski S; Johnson A; Depauw N; Rosado N; Specht MC; Liao EC; Jimenez RB
    Acta Oncol; 2021 Nov; 60(11):1440-1451. PubMed ID: 34313520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer.
    Huang Q; Jabbour SK; Xiao Z; Yue N; Wang X; Cao H; Kuang Y; Zhang Y; Nie K
    Radiat Oncol; 2018 Apr; 13(1):78. PubMed ID: 29695284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients.
    Franceschini D; Cozzi L; Fogliata A; Marini B; Di Cristina L; Dominici L; Spoto R; Franzese C; Navarria P; Comito T; Reggiori G; Tomatis S; Scorsetti M
    Radiat Oncol; 2022 Aug; 17(1):150. PubMed ID: 36028862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards the clinical implementation of intensity-modulated proton therapy for thoracic indications with moderate motion: Robust optimised plan evaluation by means of patient and machine specific information.
    Ribeiro CO; Visser S; Korevaar EW; Sijtsema NM; Anakotta RM; Dieters M; Both S; Langendijk JA; Wijsman R; Muijs CT; Meijers A; Knopf A
    Radiother Oncol; 2021 Apr; 157():210-218. PubMed ID: 33545257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclotron and linear accelerator generated scanning proton beams for lung cancer SBRT: Interplay effects and mitigations.
    Liu CW; Kolano AM; Gray T; Stephans KL; Videtic GMM; Farr JB; Xia P
    Med Phys; 2024 Jun; 51(6):3985-3994. PubMed ID: 38683935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of beam angle choice on pencil beam scanning breath-hold proton therapy for lung lesions.
    Gorgisyan J; Perrin R; Lomax AJ; Persson GF; Josipovic M; Engelholm SA; Weber DC; Munck Af Rosenschold P
    Acta Oncol; 2017 Jun; 56(6):853-859. PubMed ID: 28464744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sparing Cardiac Substructures With Optimized Volumetric Modulated Arc Therapy and Intensity Modulated Proton Therapy in Thoracic Radiation for Locally Advanced Non-small Cell Lung Cancer.
    Ferris MJ; Martin KS; Switchenko JM; Kayode OA; Wolf J; Dang Q; Press RH; Curran WJ; Higgins KA
    Pract Radiat Oncol; 2019; 9(5):e473-e481. PubMed ID: 31077884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ sparing potential and inter-fraction robustness of adaptive intensity modulated proton therapy for lung cancer.
    van der Laan HP; Anakotta RM; Korevaar EW; Dieters M; Ubbels JF; Wijsman R; Sijtsema NM; Both S; Langendijk JA; Muijs CT; Knopf AC
    Acta Oncol; 2019 Dec; 58(12):1775-1782. PubMed ID: 31556764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.